(Q41702922)

7 October 2017

Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor (English)

1 reference

7 October 2017

H Schätzl

1

1 reference

7 October 2017

H R Gelderblom

series ordinal

2

1 reference

7 October 2017

H Nitschko

series ordinal

3

1 reference

7 October 2017

K von der Helm

series ordinal

4

1 reference

7 October 2017

1 January 1991

1 reference

7 October 2017

11

1 reference

inferred from page(s)

published in

Archives of Virology

1 reference

7 October 2017

120

1 reference

7 October 2017

71-81

1 reference

7 October 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01310950

7 October 2017

0 references

cites work

Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A

1 reference

12 December 2020

Properties of avian retrovirus particles defective in viral protease

1 reference

12 December 2020

Rational design of peptide-based HIV proteinase inhibitors

1 reference

12 December 2020

Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli.

1 reference

12 December 2020

Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins

1 reference

12 December 2020

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

1 reference

12 December 2020

Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A

1 reference

12 December 2020

An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection

1 reference

12 December 2020

Morphogenesis and morphology of HIV. Structure-function relations

1 reference

12 December 2020

Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity.

1 reference

12 December 2020

Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease

1 reference

12 December 2020

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

1 reference

12 December 2020

Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody.

1 reference

12 December 2020

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

1 reference

12 December 2020

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

12 December 2020

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

12 December 2020

Plasma viremia in human immunodeficiency virus infection

1 reference

12 December 2020

A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01310950

1 reference

7 October 2017

1 reference